OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
50
Results
Show all
Save search
Copy query
Show results for
Unknown
(50)
Publication Date
Release Date
2021
(10)
2023
(8)
2022
(6)
2024
(4)
2018
(4)
2017
(4)
2015
(4)
2025
(3)
2019
(3)
2020
(1)
2016
(1)
2014
(1)
2013
(1)
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2
+
Breast Cancer.
Not available
S-EPMC5762201
|
biostudies-literature
Cite
Diagnostic test accuracy of a novel smartphone application for the assessment of attention deficits in delirium in older hospitalised patients: a prospective cohort study protocol.
Not available
S-EPMC6142423
|
biostudies-literature
Cite
A smartphone-based test for the assessment of attention deficits in delirium: A case-control diagnostic test accuracy study in older hospitalised patients.
Not available
S-EPMC6980392
|
biostudies-literature
Cite
Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancer.
Not available
S-EPMC6675908
|
biostudies-literature
Cite
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Not available
S-EPMC7787219
|
biostudies-literature
Cite
Associations of Total Legume, Pulse, and Soy Consumption with Incident Type 2 Diabetes: Federated Meta-Analysis of 27 Studies from Diverse World Regions.
Not available
S-EPMC8112771
|
biostudies-literature
Cite
Electromagnetic Stimulation to Reduce Disability After Ischemic Stroke: The EMAGINE Randomized Clinical Trial.
Not available
S-EPMC12534854
|
biostudies-literature
Cite
The somatic genomic landscape of chromophobe renal cell carcinoma.
Not available
S-EPMC4160352
|
biostudies-literature
Cite
Discovery and functional prioritization of Parkinson's disease candidate genes from large-scale whole exome sequencing.
Not available
S-EPMC5282828
|
biostudies-literature
Cite
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002).
Not available
S-EPMC8409975
|
biostudies-literature
Cite
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets